Clopidogrel vs ticlopidine: tolerability after coronary stenting

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1436, 2004-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel an alternative to ticlopidine in coronary stenting

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Cilostazol outperforms ticlopidine after coronary stenting

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clopidogrel + eptifibatide CLEARs PLATELETS after coronary stenting

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients

Heart Drug, Vol. 5, Iss. 4, 2005-12 ,pp. : 187-192

Karger

Access to resources Recommend Favorite

Clopidogrel Resistance: Implications for Coronary Stenting

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite